Veterinary Vaccines Market to clock a healthy 6.9% CAGR between 2017 and 2024

Global Veterinary Vaccines Market: Snapshot

The global veterinary vaccines market is rising at a healthy pace on the back of rising incidence of animal diseases. Climate changes and rising global warming have been related to outbreak of animal diseases, some of which are transmissible to humans. Zoonotic diseases that originate in wildlife account for 61% of animal diseases. Also, most zoonotic infections in humans are transmitted through livestock.

Apart from this, increasing spending on companion animals due to growing bonding between pet owners and their pets is stoking demand for animal healthcare products. In addition, awareness programs organized by animal welfare groups have also been instrumental to raise awareness about animal diseases among pet and livestock owners. This is boosting the veterinary vaccines market.

Read Report Overview: https://www.transparencymarketresearch.com/veterinary-vaccines-market.html

However, high R&D costs that are increasing every year are preventing development of novel products. This poses as a bottleneck to the market’s growth. Considering a host of positive factors, the global veterinary vaccines market is forecasted to clock a healthy 6.9% CAGR between 2017 and 2024.

Demand for Animal Protein Foods Makes Livestock Vaccines Segment Rank Higher

The global veterinary vaccines market is segmented depending upon technology, animal type, and region. In terms of technology, inactivated vaccines, conjugate vaccines, live attenuated vaccines, toxoid vaccines, and other vaccines are the key segments into which the veterinary vaccines market is divided. Out of these, live attenuated vaccines segment holds dominance in the veterinary vaccines market; going ahead, the segment is anticipated to witness strong growth. The growth of live attenuated vaccines segment is predominantly because of rising number of farm and companion animals and due to their widespread use for poultry.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=215

The segment of inactivated vaccines, on the other hand, is a prominent one due to outbreaks of animal diseases, and rise in incidence of zoonotic diseases; the inactivated vaccines segment is anticipated to be worth US$3,951.1 mn by 2024.

The DNA vaccines segment displays the leading growth rate amongst other technology type segments in the veterinary vaccines market.

In terms of animal type, livestock vaccines segment dominates the veterinary vaccines market. Within livestock segment, poultry vaccines hold the leading share of the overall market followed by porcine vaccines. Diseases among pigs such as porcine reproductive and respiratory syndrome (PRRS) and growing public awareness are key factors driving the poultry vaccines segment. The bovine vaccines segment within livestock vaccines segment holds significant share as bovine respiratory disease and foot-and-mouth disease are common among cattle.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=215

On the other hand companion animal vaccines segment witnessed rapid growth in the recent past. This is mainly because of increasing number of pet owners, increasing awareness among pet owners about importance of vaccination for pets, and rising prevalence of zoonotic diseases among humans.

Government Mandates for Vaccination of Animals in U.S. Makes North America Leader

Geography-wise, the key regions into which the veterinary vaccines market is classified are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among them, North America holds supremacy in the veterinary vaccines market owing to organized nature of livestock farms and highest number of pets in the U.S. globally. Strict government mandates for vaccinating animals against diseases accounts for high demand for veterinary vaccines in the U.S.

Some of the companies operating in the worldwide veterinary vaccines market are Zoetis Inc., Merck and Co., Bayer AG, Bimeda Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lily and Company, and Sanofi S.A. among others.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.